Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Maximilian Arends

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Innere Medizin (Heidelberg, Germany)|September 23, 2022
[Clonal hematopoiesis and solid neoplasms]Christopher Maximilian Arends, Frederik Damm
International Journal of Hematology|August 7, 2024
Dynamics of clonal hematopoiesis and risk of hematologic malignancyChristopher Maximilian Arends, Siddhartha Jaiswal
Cancers|April 12, 2022
Refining AML Treatment: The Role of Genetics in Response and Resistance Evaluation to New AgentsAdriane Halik, Christopher Maximilian Arends, Lars Bullinger, et al.
Leukemia|April 18, 2024
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
Blood|January 6, 2026
Clonal Hematopoiesis and Lymphoma-Associated Mutations in Hematopoietic Progenitors in B-Cell Non-Hodgkin LymphomaLaura Wiegand, Patricia Silva, Daniel Noerenberg, et al.
Leukemia|March 2, 2018
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesisChristopher Maximilian Arends, Joel Galan-Sousa, Kaja Hoyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2018
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell TransplantationMareike Frick, Willy Chan, Christopher Maximilian Arends, et al.
Blood|September 28, 2016
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphomaLarry Mansouri, Daniel Noerenberg, Emma Young, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Innere Medizin (Heidelberg, Germany)|September 23, 2022
[Clonal hematopoiesis and solid neoplasms]Christopher Maximilian Arends, Frederik Damm
International Journal of Hematology|August 7, 2024
Dynamics of clonal hematopoiesis and risk of hematologic malignancyChristopher Maximilian Arends, Siddhartha Jaiswal
Cancers|April 12, 2022
Refining AML Treatment: The Role of Genetics in Response and Resistance Evaluation to New AgentsAdriane Halik, Christopher Maximilian Arends, Lars Bullinger, et al.
Leukemia|April 18, 2024
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
Blood|January 6, 2026
Clonal Hematopoiesis and Lymphoma-Associated Mutations in Hematopoietic Progenitors in B-Cell Non-Hodgkin LymphomaLaura Wiegand, Patricia Silva, Daniel Noerenberg, et al.
Leukemia|March 2, 2018
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesisChristopher Maximilian Arends, Joel Galan-Sousa, Kaja Hoyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2018
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell TransplantationMareike Frick, Willy Chan, Christopher Maximilian Arends, et al.
Blood|September 28, 2016
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphomaLarry Mansouri, Daniel Noerenberg, Emma Young, et al.
Pageof 1